Last reviewed · How we verify
NCT06561828
Developing Transcranial Neuromodulation Protocols for Learning and Decision-Making
EARLY_PHASE1 trial testing continuous Theta Burst Stimulation (cTBS) in Normal Physiology in 600 participants. Currently enrolling.
1 November 2044
Quick facts
| Lead sponsor | National Institute on Drug Abuse (NIDA) |
|---|---|
| Phase | EARLY_PHASE1 |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | basic science |
| Enrollment | 600 |
| Start date | 22 April 2026 |
| Primary completion | 1 November 2044 |
| Estimated completion | 2 November 2044 |
| Sites | 1 location across United States |
Drugs / interventions tested
- continuous Theta Burst Stimulation (cTBS)
- intermittent Theta Burst Stimulation (iTBS)
- sham Theta Burst Stimulation (sham TBS)
Conditions studied
- Normal Physiology — all drugs for Normal Physiology →
Sponsor
National Institute on Drug Abuse (NIDA)
Who can join
Adults 18 to 45, any sex, with Normal Physiology. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background: People with substance use disorder (SUD) often have changes in brain function that can make it difficult to control drug-seeking behavior. These changes may heighten the urge to use drugs or lessen the desire to seek nondrug-related rewards. Researchers want to know how a technique called transcranial magnetic stimulation (TMS) may cause changes in brain activity that may help people with SUD. Objective: To test TMS in healthy volunteers. Eligibility: Healthy people aged 18 to 45 years who are right-handed. Design: Participants can volunteer for up to 5 different experiments. Each experiment requires 2 to 8 clinic visits. Each visit will last 3 to 7 hours. Some visits will include TMS. A coil will be placed on the participant s head. A brief electrical current will pass through the coil to create a magnetic field. Participants may feel a tapping or pulling sensation on the skin under the coil. They may feel a twitch in their face, neck, arm, or leg muscles. Participants may be asked to tense certain muscles during TMS. Some visits will include functional magnetic resonance imaging (fMRI) scans. Participants will lie on a bed that slides into a large tube. They will perform tasks on a computer inside the tube. The fMRI will show which parts of the brain are used during each task. Participants will perform tasks on a computer. Some tasks may be done at a desk as well as during TMS and fMRI. Participants may look at images, listen to sounds, smell odors, or taste flavored liquids. Their vital signs may be monitored and their eye movements may be tracked during tasks.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06561828
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Normal Physiology
Currently open trials in the same condition.
- NCT05666739 — NIEHS Repository of Stored Biological Samples for Future Use · recruiting
- NCT05829044 — Impact of Sex and Age on Non-visual Light Input That Affects Sleep and Circadian Rhythms · NA · recruiting
- NCT06050603 — MRI Guided Closed-loop TMS-EEG · NA · recruiting
- NCT05545306 — The Effects of Increasing Caloric Intake on Diet-Induced Thermogenesis and 24h Energy Expenditure · NA · recruiting
- NCT05707806 — Development and Validation of Learning and Decision-Making Tasks · recruiting
Other National Institute on Drug Abuse (NIDA) trials
Trials by the same sponsor.
- NCT07468552 — Trial of Tirzepatide for the Treatment of Cannabis Use Disorder · Phase 2 · not yet recruiting
- NCT06808932 — VK4-116 Phase I Study With Food-Effect · Phase 1 · not yet recruiting
- NCT06676059 — SMART-r: Substance Monitoring and Active Relapse Tracking Repository · recruiting
- NCT06577454 — Measuring the Effects of Neurostimulation on Risky and Ambiguous Decision-Making Capacity in People With and Without Sub · NA · suspended
- NCT06868914 — Phase I Trial of High-Density Theta Burst Stimulation (hdTBS) · Phase 1 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06561828 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Institute on Drug Abuse (NIDA)
- Last refreshed: 17 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06561828.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing